ArticleBritish journal of cancer2014

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer.

D J Jonker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.